Crinetics Pharmaceuticals Inc (CRNX) Insider Trading
- $45,793,090.74
- $78,827,804.57
- Oct. 3, 2024
- Stephen F Betz
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Oct. 3, 2024 | Insider | 14,375 | $54.63 | Sell | $785,306.25 | |
Sept. 26, 2024 | CFO | 25,000 | $51.11 | Sell | $1,277,750.00 | |
Sept. 10, 2024 | Insider | 1,035 | $51.50 | Sell | $53,302.50 | |
Aug. 26, 2024 | Insider | 3,000 | $53.19 | Sell | $159,570.00 | |
July 25, 2024 | CFO | 19,056 | $53.88 | Sell | $1,026,737.28 | |
July 25, 2024 | Insider | 3,000 | $53.43 | Sell | $160,290.00 | |
July 15, 2024 | COO | 27,000 | $55.00 | Sell | $1,485,000.00 | |
July 15, 2024 | CFO | 25,000 | $55.00 | Sell | $1,375,000.00 | |
July 10, 2024 | Insider | 3,000 | $48.55 | Sell | $145,650.00 | |
July 5, 2024 | Insider | 15,000 | $44.08 | Sell | $661,200.00 | |
July 3, 2024 | Insider | 14,375 | $44.87 | Sell | $645,006.25 | |
June 28, 2024 | CFO | 32,129 | $43.61 | Sell | $1,401,145.69 | |
June 26, 2024 | COO | 956 | $44.38 | Sell | $42,427.28 | |
June 24, 2024 | Insider | 9,500 | $45.73 | Sell | $434,435.00 | |
June 21, 2024 | Insider | 15,000 | $44.66 | Sell | $669,900.00 | |
June 10, 2024 | Insider | 3,000 | $43.86 | Sell | $131,580.00 | |
May 28, 2024 | Insider | 3,000 | $47.49 | Sell | $142,470.00 | |
May 10, 2024 | Insider | 3,000 | $49.43 | Sell | $148,290.00 | |
May 8, 2024 | CEO | 107,448 | $49.40 | Sell | $5,307,931.20 | |
April 15, 2024 | Insider | 14,375 | $44.47 | Sell | $639,256.25 | |
April 4, 2024 | CEO | 40,951 | $49.17 | Sell | $2,013,560.67 | |
March 28, 2024 | Director | 17,500 | $46.38 | Sell | $811,650.00 | |
March 22, 2024 | COO | 32,359 | $44.31 | Sell | $1,433,827.29 | |
March 20, 2024 | Director | 60,000 | $44.14 | Sell | $2,648,400.00 | |
March 20, 2024 | Insider | 15,089 | $44.06 | Sell | $664,821.34 | |
March 19, 2024 | CFO | 6,942 | $42.91 | Sell | $297,881.22 | |
Jan. 25, 2024 | Insider | 3,000 | $37.26 | Sell | $111,780.00 | |
Jan. 10, 2024 | Insider | 3,000 | $37.65 | Sell | $112,950.00 | |
Jan. 3, 2024 | Insider | 14,375 | $35.00 | Sell | $503,125.00 | |
Jan. 2, 2024 | CFO | 10,000 | $35.47 | Sell | $354,700.00 | |
Dec. 26, 2023 | Insider | 3,000 | $35.89 | Sell | $107,670.00 | |
Dec. 21, 2023 | Insider | 9,583 | $34.57 | Sell | $331,284.31 | |
Dec. 11, 2023 | Insider | 3,000 | $32.87 | Sell | $98,610.00 | |
Nov. 27, 2023 | Insider | 3,000 | $31.84 | Sell | $95,520.00 | |
Nov. 3, 2023 | CEO | 199,082 | $30.56 | Sell | $6,083,945.92 | |
Nov. 1, 2023 | CFO | 10,000 | $28.75 | Sell | $287,500.00 | |
Oct. 17, 2023 | Insider | 7,000 | $30.00 | Sell | $210,000.00 | |
July 13, 2023 | CEO | 14,157 | $20.35 | Sell | $288,094.95 | |
July 11, 2023 | CEO | 24,384 | $20.14 | Sell | $491,093.76 | |
June 20, 2023 | CFO | 30,922 | $19.97 | Sell | $617,512.34 | |
June 16, 2023 | CEO | 50,000 | $20.81 | Sell | $1,040,500.00 | |
June 8, 2023 | Director | 5,000 | $22.06 | Buy | $110,300.00 | |
April 5, 2023 | Insider | 8,212 | $16.15 | Sell | $132,623.80 | |
Jan. 25, 2023 | Insider | 8,336 | $21.07 | Sell | $175,639.52 | |
Jan. 17, 2023 | Insider | 3,126 | $18.00 | Sell | $56,268.00 | |
Dec. 15, 2022 | Insider | 3,126 | $16.00 | Sell | $50,016.00 | |
Dec. 1, 2022 | Insider | 3,126 | $17.84 | Sell | $55,767.84 | |
Nov. 15, 2022 | Insider | 3,126 | $18.72 | Sell | $58,518.72 | |
Oct. 17, 2022 | Insider | 3,126 | $17.73 | Sell | $55,423.98 | |
Oct. 3, 2022 | Insider | 3,126 | $19.64 | Sell | $61,394.64 |
Insiders are both buying and selling Crinetics Pharmaceuticals Inc stock.
The insider traders at Crinetics Pharmaceuticals Inc are: Stephen F Betz, Vivo Capital Viii, Llc, Richard Scott Struthers, Marc Wilson, Dana Pizzuti, Matthew K Fust, Jeff E Knight, Perceptive Advisors Llc, Ventures Iv L.P. 5Am, James Hassard, Alan Seth Krasner, Fust Matthew K, Stephanie Okey, Coelho Rogerio Vivaldi, Ajay Madan, Vivo Capital Fund Viii, L.P., and Life Sciences Maste Perceptive
The most active insider trader at Crinetics Pharmaceuticals Inc is Stephen F Betz with 37 trades.
Richard Scott Struthers has sold the most Crinetics Pharmaceuticals Inc stock with a total value of $25,811,785.77.
Perceptive Advisors Llc has bought the most Crinetics Pharmaceuticals Inc stock with a total value of $35,759,962.44.
The most recent insider trade for Crinetics Pharmaceuticals Inc was on Oct. 3, 2024.
The single biggest insider buy for Crinetics Pharmaceuticals Inc was from Perceptive Advisors Llc with a total value of $23,760,000.00 on Oct. 25, 2021.
The single biggest insider sell for Crinetics Pharmaceuticals Inc was from Vivo Capital Fund Viii, L.P. with a total value of $9,278,250.00 on March 20, 2019.